MedPath

Hypertension and Sleep Disordered Breathing in Pediatrics

Completed
Conditions
Hypertension
Obstructive Sleep Apnea
Registration Number
NCT00990899
Lead Sponsor
NYU Langone Health
Brief Summary

The primary objective is to determine the prevalence of sleep disordered breathing in children with primary hypertension or pre hypertension. The secondary objectives are to determine any association factors for children with primary hypertension or prehypertension to have sleep disordered breathing be it gender, age, body mass index (BMI), family history (hx) or ethnic group.

Detailed Description

This is an exploratory, cross sectional study involving identification of the children of the age between 10 years and 17 years diagnosed with primary hypertension who have not been previously diagnosed and or treated for sleep disordered breathing with the revised pediatric sleep questionaire (PSQ) for sleep disordered breathing. The subjects that have shown interest will be mailed the informed consent/assent form to tbe reviewed. The consent/assent form will be handed to the child and all their questions and concerns will be answered in a comprehensible manner.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • aged 10 to 17 years old diagnosed with primary hypertension
Exclusion Criteria
  • refused to participate in the study
  • children to secondary hypertension
  • previously diagnosed with sleep disordered breathing

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Winthrop University Hospital

🇺🇸

Mineola, New York, United States

© Copyright 2025. All Rights Reserved by MedPath